Source: International Congress 2018 – Rare lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Welte (Hannover, Germany). Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD). International Congress 2018 – Rare lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Lung transplantation (LTx) for fibrotic diseases: a single centre experience Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD) Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 328s Year: 2003 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Pulmonary function and respiratory complications in hematopoietic cell transplant Source: International Congress 2016 – Quality and quantity in lung function Year: 2016 Obstructive and restrictive pulmonary function defect after chronic GVHD and lung transplantation: a pathologist’s view Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 A new biomarker for chronic lung allograft dysfunction Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes Year: 2014 CF lung disease and lung transplantation Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018